shipra joshi

17
MARKET INTELLIGENCE . CONSULTING www.techsciresearch.com 2016 2026 ASIA PACIFIC CANCER DIAGNOSTICS MARKET FORECAST & OPPORTUNITIES

Upload: techsci_research

Post on 08-Apr-2021

7 views

Category:

Health & Medicine


0 download

DESCRIPTION

According to #TechSci Research report, the increasing prevalence of diseases is expected to drive the growth of Asia-Pacific cancer diagnostics market during the forecast period. Report URL- https://bit.ly/3wCd8Qu Visit our website @ https://www.techsciresearch.com/ For more market research news visit our blog: https://techsciblog.com/

TRANSCRIPT

  • MARKET INTELLIGENCE . CONSULTING

    www.techsciresearch.com

    2016 – 2026

    ASIA PACIFIC CANCER DIAGNOSTICS MARKET

    FORECAST & OPPORTUNITIES

  • 2

    Scope of ReportProduct of Interest (POI): Cancer Diagnostics

    Review Period

    2016 – 2019

    Base Year

    2020

    Estimated Year

    2021

    Forecast Period

    2022 – 2026

    Year Range

    CANCER DIAGNOSTICS MARKET

    END USER TECHNOLOGY

    • Platform based

    • Instrument based

    • Tumour biomarker

    tests

    APPLICATION

    • Lung cancer

    • Breast cancer

    • Colorectal cancer

    • Prostate cancer

    • Kidney Cancer

    • Skin cancer

    • Others

    • Diagnostic Centres

    • Hospitals and

    Clinics

    • Research Institutes

    • Others

    Process of identification of cancer disease or condition from its signs and symptoms is knownas caner diagnostics. Cancer diagnostics involve methods such as lab testing, genetic testing,imaging testing, biomarkers testing, among others for the diagnosis of different kinds ofcancers.

    Market Segmentation

    DIAGNOSTIC TYPE

    • Lab Testing

    • Genetic Testing

    • Imaging Testing

    • Biomarkers Testing

    • In Vitro Diagnostic Testing

    • Biopsy

    • OthersCOUNTRY

    • China

    • India

    • Japan

    • South Korea

    • Australia

    • Singapore

    • Malaysia

    • Indonesia

    • Philippines

    • Thailand

  • 3

    Table of Contents

    S. No. Contents Page No.

    1. Product Overview (Definition of product and major terminologies used in the report)

    2.Research Methodology (Detailed description of the methodology used to conduct the research, Raw data backup, list of all secondary sources, List of respondents for primary surveys)

    3. Executive Summary

    4. Voice of Customer

    5. Asia Pacific Cancer Diagnostics Market Outlook

    5.1. Market Size & Forecast

    5.1.1. By Value

    5.2. Market Share & Forecast

    5.2.1.By Diagnostic Type (Lab Testing, Genetic Testing, Imaging Testing, Biomarkers Testing,In Vitro Diagnostic Testing, Biopsy and Others)

    5.2.2. By Technology (Platform based, Instrument based, Tumour biomarker tests)

    5.2.3.By Application (Lung cancer, Breast cancer, Colorectal cancer, Prostate cancer, KidneyCancer, Skin cancer, Others)

    5.2.4. By End User (Diagnostic Centres, Hospitals and Clinics, Research Institutes and Others)

    5.2.5. By Country

    5.2.6. By Company (2020)

    5.3. Product Market Map

    6. China Cancer Diagnostics Market Outlook

    6.1. Market Size & Forecast

    6.1.1. By Value

    6.2. Market Share & Forecast

    6.2.1. By Diagnostic Type

  • 4

    Table of Contents

    S. No. Contents Page No.

    6.2.2. By Technology

    6.2.3. By Application

    6.2.4. By End User

    7. India Cancer Diagnostics Market Outlook

    7.1. Market Size & Forecast

    7.1.1. By Value

    7.2. Market Share & Forecast

    7.2.1. By Diagnostic Type

    7.2.2. By Technology

    7.2.3. By Application

    7.2.4. By End User

    8. Japan Cancer Diagnostics Market Outlook

    8.1. Market Size & Forecast

    8.1.1. By Value

    8.2. Market Share & Forecast

    8.2.1. By Diagnostic Type

    8.2.2. By Technology

    8.2.3. By Application

    8.2.4. By End User

    9. South Korea Cancer Diagnostics Market Outlook

    9.1. Market Size & Forecast

  • 5

    Table of Contents

    S. No. Contents Page No.

    9.1.1. By Value

    9.2. Market Share & Forecast

    9.2.1. By Diagnostic Type

    9.2.2. By Technology

    9.2.3. By Application

    9.2.4. By End User

    10. Australia Cancer Diagnostics Market Outlook

    10.1. Market Size & Forecast

    10.1.1. By Value

    10.2. Market Share & Forecast

    10.2.1. By Diagnostic Type

    10.2.2. By Technology

    10.2.3. By Application

    10.2.4. By End User

    11. Singapore Cancer Diagnostics Market Outlook

    11.1. Market Size & Forecast

    11.1.1. By Value

    11.2. Market Share & Forecast

    11.2.1. By Diagnostic Type

    11.2.2. By Technology

    11.2.3. By Application

    11.2.4. By End User

    12. Malaysia Cancer Diagnostics Market Outlook

  • 6

    Table of Contents

    S. No. Contents Page No.

    12.1. Market Size & Forecast

    12.1.1. By Value

    12.2. Market Share & Forecast

    12.2.1. By Diagnostic Type

    12.2.2. By Technology

    12.2.3. By Application

    12.2.4. By End User

    13. Indonesia Cancer Diagnostics Market Outlook

    13.1. Market Size & Forecast

    13.1.1. By Value

    13.2. Market Share & Forecast

    13.2.1. By Diagnostic Type

    13.2.2. By Technology

    13.2.3. By Application

    13.2.4. By End User

    14. Philippines Cancer Diagnostics Market Outlook

    14.1. Market Size & Forecast

    14.1.1. By Value

    14.2. Market Share & Forecast

    14.2.1. By Diagnostic Type

    14.2.2. By Technology

    14.2.3. By Application

    14.2.4. By End User

  • 7

    Table of Contents

    S. No. Contents Page No.

    15. Thailand Cancer Diagnostics Market Outlook

    15.1. Market Size & Forecast

    15.1.1. By Value

    15.2. Market Share & Forecast

    15.2.1. By Diagnostic Type

    15.2.2. By Technology

    15.2.3. By Application

    15.2.4. By End User

    16. Market Dynamics (This chapter assesses the major demand drivers and restraints.)

    16.1. Drivers

    16.2. Challenges

    17.Market Trends & Developments (This section captures recent trends pertaining to manufacturing or consumption, market movements in terms of points of production and consumption, advancements and development)

    18. Impact of COVID-19 on Asia Pacific Cancer Diagnostics Market

    19. Market Trends & Developments

    20. Competitive Landscape

    20.1. Competition Outlook

    20.2. Company Profiles (Leading Companies)

    20.2.1. Company Details

    20.2.2. Products & Services

    20.2.3. Financials (As Reported)

    20.2.4. Key Market Focus & Geographical Presence

    20.2.5. Recent Developments

  • 8

    Table of Contents

    S. No. Contents Page No.

    20.2.6. Key Management Personnel

    21.Strategic Recommendations (Based on the findings of the report strategic recommendations on how to enter and expand market share)

    22. About Us & Disclaimer

  • RESEARCH METHODOLOGY

  • 10

    Research Methodology

    ✓ Identifying Key Opinion

    Leaders

    ✓ Questionnaire Design

    ✓ In-depth Interviews

    Data Collection

    Developing list of respondents

    Formulating Questionnaire

    Market Profiling

    Data Validation

    Data Analysis

    In-depth secondary research was conducted to

    determine top players in the Asia Pacific cancer

    diagnostics market, overall market size and segmental

    market size.

    In order to conduct industry experts’

    interviews, TechSci formulated a detailed

    discussion guide.

    List of industry players and industry

    specialists was developed.

    TechSci conducted interviews with

    industry experts and industry players for data collection and

    verification.

    Data obtained as a result of primary and secondary research was

    validated through rigorous

    triangulation.

    The data was scrutinized using MS-Excel, statistical

    tools and internal proprietary database to obtain qualitative and

    quantitative insights about the Asia Pacific cancer

    diagnostics market.

    Data

    Collection

    Data Filter

    & AnalysisResearch &

    Intelligence

    Actionable

    InsightsBusiness

    Solution

    Primary Research Desk Research Company Analysis

    ✓ Recent Developments

    ✓ Market Changing

    Aspects/Dynamics

    ✓ Government Policies

    ✓ Final Conclusion

    ✓ Market Participants

    ✓ Key Strengths

    ✓ LinkedIn✓ TechSci Internal

    Database

    ✓ Factiva✓ Hoovers

    Paid Sources

    ✓ Company Websites✓ Company Annual

    Reports✓ White Paper Study✓ Financial Reports✓ Investor

    Presentations✓ Regulatory Body✓ Associations, etc.

    Secondary Research

    Primary Research

  • 11

    Research Methodology

    Baseline Methodology

    Our dedicated team of industry experts has monitored and analyzed various aspects of Asia Pacific cancer diagnostics market. Anticipated growth in

    the market can be attributed to growing demand for additive manufacturing. The team has analyzed the outlook of various segments of this market,

    while considering the major influencing factors and speculated a positive growth during the next five years. The study includes market forecasting,

    which would enable our clients to take better decisions while planning their strategy to achieve sustainability in Asia Pacific cancer diagnostics market.

    Methodology Followed for Calculation of Market Size:

    • Market Size by Value: Market size, in terms of value, for the year 2020 was calculated based on information collected through exhaustive

    secondary research and primary surveys, with various key opinion leaders/stakeholders, such as cancer diagnostics companies, channel partners,

    market influencers & end users, industry experts, and other industry participants.

    • The team interviewed more than 15 – 20 cancer diagnostics companies, 45 – 50 channel partners, 80 – 100 end users, and 15 – 20 industry experts

    and other value chain stakeholders in the Asia Pacific cancer diagnostics market to obtain the overall market size from 2016 to 2020, which was

    validated by the Delphi technique. Taking standard deviation into consideration, the market size was averaged out, to arrive at the market size data

    during 2016-2020.

    • Respondents were asked about the current and future market growth rates, market shares by diagnostic type, by technology, by application, by end

    user, by country and by company. Removing the outlier responses, the geometric mean of growth estimates and supplier wise revenue shares

    generated across various segments were considered, to arrive at the final revenue shares.

  • 12

    Research Methodology

    Revenue shares generated across various segments were further triangulated from other stakeholders.

    Methodology Followed for Calculation of Market Shares:

    Market shares by diagnostic type, by technology, by application, by end user, by country and by company were calculated based on the responses

    received through primary surveys with industry experts, in which the respondents were asked about the market shares or revenue generated from

    various segments of cancer diagnostics market. The final shares were calculated by taking the geometric mean of the responses gathered from key

    opinion leaders after eliminating the outliers.

    Methodology Followed for Forecasting:

    • TechSci Research performed periodical checks on data collected through the surveys with logic checks and analyzed the survey results in

    SPSS/Tableau Software.

    • Data triangulation techniques were applied to fill the gaps and to present a more meaningful picture of the market. To forecast Asia Pacific cancer

    diagnostics market, TechSci Research used various forecast techniques such as:

    ✓ Moving Average

    ✓ Time Series Analysis

    ✓ Regression Analysis

    ✓ Econometric and Judgmental Analysis

  • 13

    Research Methodology

    TechSci Research used its own forecast tool, which is based on the growth of various allied industries in respective regions. TechSci Research also used

    the impact analysis during short, medium and long term period to estimate the demand and to reach accurate market numbers. It should be noted that

    the figures compiled are only for the organized market including market share data. The currency used in the report is the United States Dollar (USD),

    with the market size indicated in USD million.

    Partial List of Companies Interviewed Key Secondary Sources

    ▪ Thermo Fisher Scientific, Inc.

    ▪ GE Healthcare (A Subsidiary of General

    Electric Company)

    ▪ Abbott Laboratories, Inc.

    ▪ Becton, Dickinson and Company

    ▪ Siemens AG

    ▪ Agilent Technologies, Inc.

    ▪ F. Hoffmann-La Roche Ltd.

    ▪ Bio Rad Laboratories Inc.

    ▪ Illumina, Inc.

    ▪ Boehringer-Ingelheim International GmbH

    ▪ World Bank

    ▪ TechSci Research Proprietary Database & Knowledge

    Repository

    ▪ Company Annual Reports

    ▪ Industry Magazines

    ▪ Industry Reports

    ▪ News Dailies

    ▪ Credible Paid Databases

  • 14

    Industry Brief

    According to TechSci Research report, “Asia-Pacific Cancer Diagnostics Market By Diagnostic Type (Lab Testing, Genetic Testing, Imaging

    Testing, Biomarkers Testing, In Vitro Diagnostic Testing, Biopsy and Others), By Technology (Platform Based, Instrument Based, Tumour

    Biomarker Tests), By Application (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Kidney Cancer, Skin cancer, Others), By

    End-User (Diagnostic Centers, Hospitals and Clinics, Research Institutes and Others), By Region, Forecast & Opportunities, 2026”, the Asia-

    Pacific cancer diagnostics market is expected to grow at a formidable CAGR during the forecast period on account of increasing trend of

    unhealthy diet amongst population in the region. This in turn leads to increased count of patients suffering from diabetes and cancer, which is

    expected to propel the market over the next five years. Furthermore, growing efforts undertaken by government to create awareness regarding

    cancer, as well as to minimize the disease burden is anticipated to positively impact the growth of market through 2026. Surging demand for

    screening tools and techniques is further spurring the growth of market. However, high cost of diagnosis might hamper the growth of market

    during forecast period. Furthermore, several side effects associated with imaging solutions is expected to impede the growth of market over the

    next few years.

    The Asia-Pacific cancer diagnostics market is segmented based on diagnostic type, technology, application, end-user, company and region.

    Based on diagnostic type, the market is categorized into lab testing, genetic testing, imaging testing, biomarkers testing, in vitro diagnostic

    testing, biopsy and others. The imaging testing segment dominated the market until 2020 and is expected to dominate the market during forecast

    period as well. This dominance can be ascribed to the fact that imaging modalities such as computed tomography scan and magnetic resonance

    imaging are quick, non-invasive, and pain-free diagnostic solutions. In addition to this, technological advancements in imaging modalities have

    contributed to the segment growth. Based on end-user, the market can be fragmented into diagnostic centers, hospitals and clinics, research

    institutes and others. The hospitals and clinics segment is expected to dominate the market during the forecast period on account of increased

    rates of adoption of technologically advanced imaging modalities and other devices which are used in the detection of cancer.

    Thermo Fisher Scientific, Inc., GE Healthcare (A Subsidiary of General Electric Company), Abbott Laboratories, Inc., Becton, Dickinson and

    Company, Siemens AG, Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd., Bio Rad Laboratories Inc., Illumina, Inc., Boehringer-Ingelheim

    International GmbH and others are some of the leading players operating in Asia-Pacific cancer diagnostics Market. The companies operating in

    the market are using Go-to-Market strategies such as product launches, mergers and acquisitions and research collaborations to boost their

    share.

    “Asia-Pacific cancer diagnostics market is expected to witness high growth in the market during the forecast years owing to increasing healthcare

    expenditure and presence of a large patient pool in the region. Additionally, thriving medical tourism industry in developing economies such as

    India, China, and Malaysia is further anticipated to spur the market growth. Also, presence of large market players along with favorable

    government policies supporting the growth of the manufacturing industry in the region is creating lucrative opportunities for the growth of cancer

    diagnostics market in the upcoming years.”, said Mr. Karan Chechi, Research Director with TechSci Research, a research based global

    management consulting firm.

  • 15

    Sample Data - Snapshot

    5.00 6.007.00 8.00

    9.00 10.0011.00 12.00

    13.00 14.0015.00

    2016 2020 2021E 2026F

    By Value (USD Million)

    Asia Pacific Cancer Diagnostics Market Size, By Value (USD Million), 2016–2026F

    CAGR By Value

    XX%CAGR By Value

    YY%

    15%

    15%

    15%

    15%

    15%

    15%

    15%

    15%

    15%

    15%

    15%

    15%

    15%

    15%

    15%

    15%

    15%

    15%

    15%

    15%

    15%

    15%

    15%

    15%

    15%

    15%

    15%

    15%

    15%

    15%

    15%

    15%

    15%

    15%

    15%

    15%

    15%

    15%

    15%

    15%

    15%

    15%

    15%

    15%

    15%

    15%

    15%

    15%

    15%

    15%

    15%

    15%

    15%

    15%

    15%

    15%

    15%

    15%

    15%

    15%

    15%

    15%

    15%

    15%

    15%

    15%

    10%

    10%

    10%

    10%

    10%

    10%

    10%

    10%

    10%

    10%

    10%

    2016

    2017

    2018

    2019

    2020

    2021E

    2022F

    2023F

    2024F

    2025F

    2026F

    Lab Testing Genetic Testing Imaging Testing Biomarkers Testing In Vitro Diagnostic Testing Biopsy Others

    Singapore Cancer Diagnostics Market Share, By Diagnostic Type, By Value, 2016–2026F

    30%

    30%

    30%

    30%

    30%

    30%

    30%

    30%

    30%

    30%

    30%

    20%

    20%

    20%

    20%

    20%

    20%

    20%

    20%

    20%

    20%

    20%

    30%

    30%

    30%

    30%

    30%

    30%

    30%

    30%

    30%

    30%

    30%

    20%

    20%

    20%

    20%

    20%

    20%

    20%

    20%

    20%

    20%

    20%

    2016

    2017

    2018

    2019

    2020

    2021E

    2022F

    2023F

    2024F

    2025F

    2026F

    Diagnostic Centres Hospitals and Clinics Research Institutes Others

    Singapore Cancer Diagnostics Market Share, By End User, By Value, 2016–2026F

  • 16

    Report Ordering

    License Type Price

    Electronic Access - Single User License $3950

    Electronic Access - Multi-User License $4950

    Custom Research License $8950

    Report Price

    To View Sample OR Purchase Report

    Report Name: ASIA PACIFIC CANCER DIAGNOSTICS MARKET

    FORECAST & OPPORTUNITIES2016 – 2026

    https://www.techsciresearch.com/report/asia-pacific-cancer-diagnostics-market/7303.html

  • About Us & Disclaimer

    TechSci Research is a global market research and consulting company with offices in the US, UK and India. TechSci Research provides market research reports in number of areas

    to organizations. The company uses innovative business Modes that focus on improving productivity, while ensuring creation of high-quality reports. The proprietary forecasting

    Modes use various analyses of both industry-specific and macroeconomic variables on a state-by-state basis to produce a unique ‘bottom-up’ Mode of a country, regional and

    global industry prospects. Combined with the detailed analysis of company activity and industry trends, the result is a uniquely rich evaluation of the opportunities available in the

    market.

    Related Reports

    • Global Self-monitoring Blood Glucose Market By Type (Type 1, Type 2, Hyperglycemia ,Hypoglycemia), By Frequency (One, Four, Others), By Product

    (Glucometer, Software, Test Strips, Lancet), By End-User (Hospital, Personal Care), By Region, Forecast & Opportunities, 2025

    • Global Electronic Skin Patches Market By Genetic Information (Cardiovascular Monitoring, Wireless Inpatient Monitoring, Diabetes Management,

    Iontophoresis Skin patches, Sweat Sensing), By Material (Silicon Based, Polymer Based and Others), By Technology (Disposable and Reusable), By End

    User (Hospitals, Ambulatory Surgical Centers and Others), By Region, Forecast & Opportunities, 2025

    The contents of this report are based on information generally available to the public from sources believed to be reliable. No representation is made that it is timely, accurate or

    complete. TechSci Research has taken due care and caution in compilation of data as this has been obtained from various sources including which it considers reliable and firsthand.

    However, TechSci Research does not guarantee the accuracy, adequacy or completeness of any information and it is not responsible for any errors or omissions or for the results

    obtained from the use of such information and especially states that it has no financial liability whatsoever to the subscribers / users of this report. The information herein, together

    with all estimates and forecasts, can change without notice. All the figures provided in this document are indicative of relative market size and are strictly for client’s internal

    consumption. Usage of the same for purpose other than internal will require prior approval of TechSci Research.

    TechSci Research – North America708 Third Avenue, Manhattan,

    New York, United States

    Tel: +1- 646- 360- 1656

    Email: [email protected]

    www.techsciresearch.com

    Disclaimer

    TechSci Research – Europe54, Old brook, Bretton,

    Peterborough,

    United Kingdom

    Email: [email protected]

    www.techsciresearch.com

    TechSci Research – Asia-PacificB – 44, Sector – 57, Noida, National Capital

    Region, U.P. - India

    Tel: +91-120-4523900

    Email: [email protected]

    www.techsciresearch.com